Monthly Archives: October 2023

Rutgers Gets $3.9M to Examine Infection Impact on Lung Disease Immunity

Rutgers University Researchers from New Jersey Medical School at Rutgers Health received a $3.9 million grant from the National Institutes of Health (NIH) to study how previous infections help or hinder the body’s subsequent response to unrelated pathogens that cause lung disease. The five-year grant will support the work of immunologists William C. Gause, Amariliz […]

AI Tool Predicts Blood Clot Risk in Hospitalized Pediatric Patients

By Shania Kennedy October 24, 2023 – Researchers at Vanderbilt University Medical Center (VUMC) have developed an artificial intelligence (AI) tool capable of accurately identifying the risk of blood clots in pediatric patients, but found that clinicians often hesitated to follow the tool’s recommendations. Blood clots are rare in pediatric patients, but patients who do develop […]

New Study Published in Cardiovascular Digital Health Journal Shows Implicity’s Algorithm Significantly Reduces AF Alert Burden in Remote Cardiac Monitoring

Research affirms Implicity’s algorithm* is highly effective at identifying patterns and classifying AF episodes into medically relevant events that require clinical action CAMBRIDGE, Mass., Oct. 24, 2023 /PRNewswire/ — Implicity, a leader in remote patient monitoring (RPM) and cardiac data management solutions, today announced the results of a clinical study published in the Cardiovascular Digital […]

A new understanding of immune response during SARS-CoV-2 breakthrough infections

While COVID-19 breakthrough infections—a SARS-CoV-2 infection that occurs after receiving COVID-19 vaccines—can occur, for healthy individuals with vaccine-induced immunity, these breakthrough infections do not often cause severe disease. There has been limited research to uncover why these breakthrough infections do not lead to severe infections, until now. A team led by researchers in the Perelman […]

Pemazyre: Dosage, side effects, cost, uses, and more

Here are answers to some frequently asked questions about Pemazyre. How does Pemazyre work? Pemazyre is a targeted therapy. It’s designed to slow or stop the growth of cancer cells. It works by inhibiting (blocking) specific proteins in cancer cells from functioning. Pemazyre targets fibroblast growth factor receptor proteins that are abnormal due to changes […]

Tackling the ‘ticking time bomb’ of cardiovascular disease

The NHS Long Term Plan identifies cardiovascular disease (CVD) as a clinical priority and the single biggest opportunity to save lives. The disease affects seven million people and is a major cause of disability and death. It costs the health system an estimated £7.4 billion and the wider economy £15.8 billion every year, but is […]

Understanding the Risk of Infection Associated With Neutrophils and Alcohol-Related Hepatitis

Alcohol-related hepatitis (AH) represents a significant health issue within the United States, resulting in thousands of hospitalizations a year. Presentation and severity of AH can vary from patient-to patient. The 30-day mortality rate is less than 5% in patients without encephalopathy, jaundice, or coagulopathy.1 However, the mortality rate increases significantly for inpatients. The 1-year mortality […]

Washington, Missouri hosting ‘Kristen Spaunhorst Blood Drive’ today

Ransomware negotiator explains process of haggling … 58 mins ago .cls-3{fill:#fff;fill-rule:evenodd} Lemay locals asked to keep an eye out after suspicious … 1 hour ago .cls-3{fill:#fff;fill-rule:evenodd} Police: 80-year-old woman missing since Monday afternoon 1 hour ago .cls-3{fill:#fff;fill-rule:evenodd} American Red Cross experiencing national blood shortage 1 hour ago .cls-3{fill:#fff;fill-rule:evenodd} Washington, Missouri hosting ‘Kristen Spaunhorst … 2 hours ago .cls-3{fill:#fff;fill-rule:evenodd} […]